The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Significance of the vimentin expression in triple-negative breast cancer.
Nami Yamashita
No relevant relationships to disclose
Eriko Tokunaga
No relevant relationships to disclose
Hiroyuki Kitao
No relevant relationships to disclose
Kimihiro Tanaka
No relevant relationships to disclose
Kenji Taketani
No relevant relationships to disclose
Hiroshi Saeki
No relevant relationships to disclose
Shinichi Aishima
No relevant relationships to disclose
Eiji Oki
No relevant relationships to disclose
Masaru Morita
No relevant relationships to disclose
Yoshihiko Maehara
No relevant relationships to disclose